PCM
MRVI icon

Philosophy Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Philosophy Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46M Sell
2,637,117
-463,205
-15% -$1.57M 0.46% 37
2025
Q4 		$10.1M Buy
3,100,322
+507,054
+20% +$1.71M 0.46% 38
2025
Q3 		$7.44M Hold
2,593,268
– – 0.3% 39
2025
Q2 		$6.25M Hold
2,593,268
– – 0.31% 34
2025
Q1 		$5.73M Buy
+2,593,268
New +$10.2M 0.41% 36

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Philosophy Capital Management's MRVI Position: Q1 2026 in Review

Philosophy Capital Management reduced its Maravai LifeSciences (MRVI) stake by 15% in Q1 2026, selling an estimated $1.57M and leaving 2,637,117 shares worth $7.46M. The position accounts for 0.46% of the portfolio, ranked #37.

Philosophy Capital Management first reported a position in MRVI in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.1M in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Philosophy Capital Management held 2,637,117 shares of Maravai LifeSciences worth $7.46M as of Q1 2026.
  • Philosophy Capital Management sold 463,205 Maravai LifeSciences shares in Q1 2026, an estimated $1.57M.
  • Maravai LifeSciences made up 0.46% of Philosophy Capital Management's portfolio in Q1 2026, its #37 holding.
  • Philosophy Capital Management first reported a position in Maravai LifeSciences in Q1 2025 and has held it in 5 quarters since.
  • Philosophy Capital Management's Maravai LifeSciences position peaked at $10.1M in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Philosophy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.